STL Index for: Ashley O’Toole
Topical Roflumilast for Plaque Psoriasis
Targeting PDE4 with the selective inhibitor roflumilast, specifically through topical cream at a concentration of 0.3%, has proven to be an effective and well-tolerated strategy for treating plaque psoriasis.
